{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:03:48Z","timestamp":1789977828105,"version":"4.0.1"},"reference-count":52,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:p>Adrenal glucocorticoid hormones are potent modulators of brain function in the context of acute and chronic stress. Both mineralocorticoid (MRs) and glucocorticoid receptors (GRs) can mediate these effects. We studied the brain effects of a novel ligand, C118335, with high affinity for GRs and modest affinity for MRs. In vitro profiling of receptor-coregulator interactions suggested that the compound is a \u201cselective modulator\u201d type compound for GRs that can have both agonistic and antagonistic effects. Its molecular profile for MRs was highly similar to those of the full antagonists spironolactone and eplerenone. C118335 showed predominantly antagonistic effects on hippocampal mRNA regulation of known glucocorticoid target genes. Likewise, systemic administration of C118335 blocked the GR-mediated posttraining corticosterone-induced enhancement of memory consolidation in an inhibitory avoidance task. Posttraining administration of C118335, however, gave a strong and dose-dependent impairment of memory consolidation that, surprisingly, reflected involvement of MRs and not GRs. Finally, C118335 treatment acutely suppressed the hypothalamus-pituitary-adrenal axis as measured by plasma corticosterone levels. Mixed GR\/MR ligands, such as C118335, can be used to unravel the mechanisms of glucocorticoid signaling. The compound is also a prototype of mixed GR\/MR ligands that might alleviate the harmful effects of chronic overexposure to endogenous glucocorticoids.<\/jats:p>","DOI":"10.1210\/en.2015-1390","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T18:09:56Z","timestamp":1440526196000},"page":"4105-4114","source":"Crossref","is-referenced-by-count":46,"title":["A Mixed Glucocorticoid\/Mineralocorticoid Selective Modulator With Dominant Antagonism in the Male Rat Brain"],"prefix":"10.1210","volume":"156","author":[{"given":"Erika","family":"Atucha","sequence":"first","affiliation":[{"name":"Department of Cognitive Neuroscience (E.A., L.T.C.M.v.W., B.R.) Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands and Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EZ Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Zalachoras","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (I.Z., J.K.v.d.H., L.T.C.M.v.W., I.M.M., O.C.M.), Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2300 RA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 K.","family":"van den Heuvel","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (I.Z., J.K.v.d.H., L.T.C.M.v.W., I.M.M., O.C.M.), Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2300 RA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa T. C. M.","family":"van Weert","sequence":"first","affiliation":[{"name":"Department of Cognitive Neuroscience (E.A., L.T.C.M.v.W., B.R.) Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands and Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EZ Nijmegen, The Netherlands"},{"name":"Department of Internal Medicine (I.Z., J.K.v.d.H., L.T.C.M.v.W., I.M.M., O.C.M.), Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2300 RA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Melchers","sequence":"first","affiliation":[{"name":"PamGene International (D.M., R.H.), 2511 HH Den Bosch, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"Mol","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (I.Z., J.K.v.d.H., L.T.C.M.v.W., I.M.M., O.C.M.), Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2300 RA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Belanoff","sequence":"first","affiliation":[{"name":"Corcept Therapeutics (J.K.B., H.H.), Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Houtman","sequence":"first","affiliation":[{"name":"PamGene International (D.M., R.H.), 2511 HH Den Bosch, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Hunt","sequence":"first","affiliation":[{"name":"Corcept Therapeutics (J.K.B., H.H.), Menlo Park, California 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno","family":"Roozendaal","sequence":"first","affiliation":[{"name":"Department of Cognitive Neuroscience (E.A., L.T.C.M.v.W., B.R.) Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands and Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EZ Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno C.","family":"Meijer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (I.Z., J.K.v.d.H., L.T.C.M.v.W., I.M.M., O.C.M.), Division of Endocrinology, Einthoven Laboratory for Experimental Vascular Medicine, and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2300 RA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"2020071612163225600_B1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"2020071612163225600_B2","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.1411216111","article-title":"Ultradian corticosterone pulses balance glutamatergic transmission and synaptic plasticity","volume":"111","author":"Sarabdjitsingh","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.npp.1300158","article-title":"Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis","volume":"28","author":"Bachmann","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"2020071612163225600_B4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2826.2007.01605.x","article-title":"Effect of the Glucocorticoid Receptor Antagonist Org 34850 on Basal and Stress-Induced Corticosterone Secretion","volume":"19","author":"Spiga","year":"2007","journal-title":"Journal of Neuroendocrinology"},{"key":"2020071612163225600_B5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.psyneuen.2010.01.011","article-title":"Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress","volume":"35","author":"Wulsin","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"2020071612163225600_B6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopsych.2006.05.034","article-title":"Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression","volume":"60","author":"DeBattista","year":"2006","journal-title":"Biol Psychiatry"},{"key":"2020071612163225600_B7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-114-2-143","article-title":"Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)","volume":"114","author":"van der Lely","year":"1991","journal-title":"Ann Intern Med"},{"key":"2020071612163225600_B8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-61-3-536","article-title":"Successful treatment of Cushing\u2019s syndrome with the glucocorticoid antagonist RU 486","volume":"61","author":"Nieman","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612163225600_B9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0032-1301921","article-title":"Psychopathological symptoms in patients with primary hyperaldosteronism\u2014possible pathways","volume":"44","author":"K\u00fcnzel","year":"2012","journal-title":"Horm Metab Res"},{"key":"2020071612163225600_B10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","article-title":"Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects","volume":"171","author":"Judd","year":"2014","journal-title":"Am J Psychiatry"},{"key":"2020071612163225600_B11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2011.07.023","article-title":"FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior","volume":"70","author":"Touma","year":"2011","journal-title":"Biol Psychiatry"},{"key":"2020071612163225600_B12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000125210","article-title":"On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation","volume":"50","author":"Ratka","year":"1989","journal-title":"Neuroendocrinology"},{"key":"2020071612163225600_B13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2008.01.002","article-title":"The concept of allostasis and allostatic load","volume":"583","author":"Jo\u00ebls","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2020071612163225600_B14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/1043-2760(91)90030-Q","article-title":"The antisteroid RU486: its cellular and molecular mode of action","volume":"2","author":"Baulieu","year":"1991","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612163225600_B15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yhbeh.2014.02.002","article-title":"The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test","volume":"65","author":"Solomon","year":"2014","journal-title":"Horm Behav"},{"key":"2020071612163225600_B16","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1073\/pnas.1219411110","article-title":"Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator","volume":"110","author":"Zalachoras","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejphar.2007.11.076","article-title":"Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems","volume":"583","author":"De Bosscher","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2020071612163225600_B18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1210\/me.2002-0355","article-title":"A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects","volume":"17","author":"Coghlan","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2020071612163225600_B19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2013.03.038","article-title":"Understanding stress-effects in the brain via transcriptional signal transduction pathways","volume":"242","author":"Zalachoras","year":"2013","journal-title":"Neuroscience"},{"key":"2020071612163225600_B20","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1073\/pnas.0812062106","article-title":"Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids","volume":"106","author":"Lachize","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/me.2007-0012","article-title":"Coregulators: from whence came these \u201cmaster genes.\u201d","volume":"21","author":"O\u2019Malley","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2020071612163225600_B22","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1016\/j.bmcl.2012.10.074","article-title":"Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat","volume":"22","author":"Hunt","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"2020071612163225600_B23","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M900209-MCP200","article-title":"Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor \u03b3 cofactor","volume":"8","author":"Koppen","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"2020071612163225600_B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4939-1346-6_8","article-title":"Cofactor profiling of the glucocorticoid receptor from a cellular environment","volume":"1204","author":"Desmet","year":"2014","journal-title":"Methods Mol Biol"},{"key":"2020071612163225600_B25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(88)91294-2","article-title":"Memory-enhancing effects of posttraining naloxone: involvement of \u03b2-noradrenergic influences in the amygdaloid complex","volume":"446","author":"McGaugh","year":"1988","journal-title":"Brain Res"},{"key":"2020071612163225600_B26","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2020071612163225600_B27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/mend.12.4.0089","article-title":"A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor","volume":"12","author":"Zhang","year":"1998","journal-title":"Mol Endocrinol"},{"issue":"3 Pt 2","key":"2020071612163225600_B28","first-page":"R710","article-title":"Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats","volume":"271","author":"Havel","year":"1996","journal-title":"Am J Physiol"},{"key":"2020071612163225600_B29","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1210\/en.2004-0411","article-title":"Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling","volume":"146","author":"Meijer","year":"2005","journal-title":"Endocrinology"},{"issue":"Pt 3","key":"2020071612163225600_B30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj2820697","article-title":"Aldosterone antagonists destabilize the mineralocorticosteroid receptor","volume":"282","author":"Couette","year":"1992","journal-title":"Biochem J"},{"key":"2020071612163225600_B31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071612163225600_B32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/mol.51.2.285","article-title":"Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone","volume":"51","author":"Massaad","year":"1997","journal-title":"Mol Pharmacol"},{"key":"2020071612163225600_B33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0039-128X(94)00001-S","article-title":"The two faces of a steroid antagonist: when an antagonist isn\u2019t","volume":"60","author":"Nordeen","year":"1995","journal-title":"Steroids"},{"key":"2020071612163225600_B34","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/MCB.13.4.2031","article-title":"Characterization of sgk, a novel member of the serine\/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum","volume":"13","author":"Webster","year":"1993","journal-title":"Mol Cell Biol"},{"key":"2020071612163225600_B35","doi-asserted-by":"crossref","first-page":"e16883","DOI":"10.1371\/journal.pone.0016883","article-title":"Expression and regulation of the Fkbp5 gene in the adult mouse brain","volume":"6","author":"Scharf","year":"2011","journal-title":"PLoS One"},{"key":"2020071612163225600_B36","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","article-title":"Epithelial sodium channel regulated by aldosterone-induced protein sgk","volume":"96","author":"Chen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B37","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1073\/pnas.1300886110","article-title":"Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis","volume":"110","author":"Anacker","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nlme.1996.0001","article-title":"Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task","volume":"65","author":"Roozendaal","year":"1996","journal-title":"Neurobiol Learn Mem"},{"key":"2020071612163225600_B39","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1210\/endo.139.5.5971","article-title":"Expression and hormonal regulation of coactivator and corepressor genes","volume":"139","author":"Misiti","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612163225600_B40","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.M510713200","article-title":"Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid\/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1\u03b1","volume":"281","author":"Miao","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071612163225600_B41","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/endo-117-6-2505","article-title":"Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation","volume":"117","author":"Reul","year":"1985","journal-title":"Endocrinology"},{"key":"2020071612163225600_B42","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1101\/gr.097022.109","article-title":"Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation","volume":"19","author":"Reddy","year":"2009","journal-title":"Genome Res"},{"key":"2020071612163225600_B43","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1460-9568.2007.05427.x","article-title":"Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia","volume":"25","author":"Lai","year":"2007","journal-title":"Eur J Neurosci"},{"key":"2020071612163225600_B44","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1523\/JNEUROSCI.1187-07.2007","article-title":"Mineralocorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory","volume":"27","author":"Ferguson","year":"2007","journal-title":"J Neurosci"},{"key":"2020071612163225600_B45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.psyneuen.2012.08.007","article-title":"Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour","volume":"38","author":"Harris","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"2020071612163225600_B46","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1073\/pnas.231313998","article-title":"Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory","volume":"98","author":"Oitzl","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B47","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0166-2236(99)01438-1","article-title":"Stress and cognition: are corticosteroids good or bad guys?","volume":"22","author":"de Kloet","year":"1999","journal-title":"Trends Neurosci"},{"key":"2020071612163225600_B48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.nlm.2010.09.005","article-title":"Both mineralocorticoid and glucocorticoid receptors regulate emotional memory in mice","volume":"94","author":"Zhou","year":"2010","journal-title":"Neurobiol Learn Mem"},{"key":"2020071612163225600_B49","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2013.06.001","article-title":"Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain","volume":"74","author":"Schwabe","year":"2013","journal-title":"Biol Psychiatry"},{"key":"2020071612163225600_B50","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/hy1001.091781","article-title":"Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats","volume":"38","author":"Rahmouni","year":"2001","journal-title":"Hypertension"},{"key":"2020071612163225600_B51","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1073\/pnas.92.26.12480","article-title":"Steroid receptor heterodimerization demonstrated in vitro and in vivo","volume":"92","author":"Liu","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612163225600_B52","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1073\/pnas.0507572102","article-title":"Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone","volume":"102","author":"Karst","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/11\/4105\/8988710\/endo4105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/11\/4105\/8988710\/endo4105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:33:49Z","timestamp":1748579629000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/156\/11\/4105\/2422854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2015-1390","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]}}}